On some of these facts that Dr. St-Onge put forward, such as Quebec having 5,000 drugs on its formulary but New Zealand only having 2,600, I'd like all three of you to answer this: do you think we've been too easy on the drug companies with respect to the licensing of drugs, particularly considering some of the problems you have raised--the comparator being a placebo or this business of surrogate markers with no validation? Is that why we have 5,000 and New Zealand only has 2,600? Are they approving fewer drugs for licensing, and that ends up with their having fewer to put on their formulary?
On May 16th, 2007. See this statement in context.